Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report

Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report

Abstract Background Ameloblastomas are uncommon locally aggressive tumors of odontogenic epithelium that rarely metastasize. Currently, there is no standard of care for the metastatic forms. Several studies have shown that ameloblastomas frequently have a BRAF mutation. Case presentation We report a...

Full description

Bibliographic Details
Main Authors: Morgane Broudic-Guibert, Jean-Yves Blay, Léa Vazquez, Alexandre Evrard, Marie Karanian, Sophie Taïeb, Natalie Hoog-Labouret, Céline Mahier Ait Oukhatar, Rania Boustany-Grenier, Antoine Arnaud
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Journal of Medical Case Reports
Subjects:
Vemurafenib
BRAF
Ameloblastoma
Metastatic
Case report
Online Access:http://link.springer.com/article/10.1186/s13256-019-2140-6

Internet

http://link.springer.com/article/10.1186/s13256-019-2140-6

Similar Items